IceCure Medical Ltd. Releases Preliminary Q2 2025 Financials
Ticker: ICCM · Form: 6-K · Filed: Jul 3, 2025 · CIK: 1584371
Sentiment: neutral
Topics: financial-results, preliminary-results, foreign-private-issuer
TL;DR
IceCure Medical dropped preliminary Q2 results on 7/3/25 - check the 6-K for details.
AI Summary
On July 3, 2025, IceCure Medical Ltd. announced preliminary financial results for the three and six months ended June 30, 2025. The company is a foreign private issuer and is furnishing this information via a Form 6-K filing, incorporating a press release titled "IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025" as Exhibit 99.1.
Why It Matters
This filing provides investors with an early look at IceCure Medical's financial performance for the second quarter of 2025, allowing for timely assessment of the company's operational and financial health.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of preliminary financial results and does not contain significant new risks or material adverse events.
Key Players & Entities
- IceCure Medical Ltd. (company) — Registrant
- July 3, 2025 (date) — Filing date and press release date
- June 30, 2025 (date) — Reporting period end date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to furnish a press release titled "IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025" as Exhibit 99.1.
What period do the preliminary financial results cover?
The preliminary financial results cover the three and six months ended June 30, 2025.
What is IceCure Medical Ltd.'s filing status with the SEC?
IceCure Medical Ltd. is a foreign private issuer and files annual reports under cover of Form 20-F.
When was the press release containing the preliminary financial results issued?
The press release was issued on July 3, 2025.
Is this filing incorporated into any other SEC filings?
Yes, this Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company's Registration Statements on Form F-3.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 3, 2025 regarding IceCure Medical Ltd. (ICCM).